|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-subunit isoforms of AMP-activated protein kinase suggests a major role for
3 in white skeletal muscle
1 Arexis AB, Gothenburg, Sweden
2 Department of Animal Breeding and Genetics, Swedish University of Agricultural Sciences, Uppsala Biomedical Center, Uppsala, Sweden
3 Department of Surgical Sciences, Karolinska Institutet, Stockholm, Sweden
* To whom correspondence should be addressed. E-mail: Stefan.Marklund{at}bmc.uu.se.
Expression patterns of the three isoforms of the regulatory
-subunit of adenosine monophosphate-activated protein kinase (AMPK) were determined in various tissues from adult humans, mice and rats, as well as in human primary muscle cells. Real-time PCR based quantification of mRNA showed similar expression patterns in the three species and a good correlation with protein expression in mice and rats. The
3-isoform appeared highly specific to skeletal muscle, whereas
1 and
2 showed broad tissue distributions. Moreover, the proportion of white, type IIb fibers in the mouse and rat muscle samples, as indicated by real-time PCR
quantification of Atp1b2 mRNA, showed a strong positive correlation to the expression of
3. In
samples of white skeletal muscle,
3 clearly appeared to be the most abundant
-isoform.
Differentiation of human primary muscle cells from myoblasts into multinucleated myotubes was accompanied by upregulation of
3-mRNA expression, while levels of
1 and
2 remained largely unchanged. However, even in these cultured myotubes,
2 was the most highly expressed isoform, indicating a considerable difference compared to adult skeletal muscle. Immunoblot analysis of mouse gastrocnemius and quadriceps muscle extracts precipitated with a
3-specific antibody showed that
3 was exclusively associated with the
2- and
2-subunit isoforms. The observation that the AMPK
3-isoform is primarily expressed in white skeletal muscle, in which it is the predominant
-isoform, strongly suggests that
3 has a key role in this tissue.
This article has been cited by other articles:
![]() |
C. T. Putman, K. J. B. Martins, M. E. Gallo, G. D. Lopaschuk, J. A. Pearcey, I. M. MacLean, R. J. Saranchuk, and D. Pette {alpha}-Catalytic subunits of 5'AMP-activated protein kinase display fiber-specific expression and are upregulated by chronic low-frequency stimulation in rat muscle Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1325 - R1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Jorgensen, J. T. Treebak, B. Viollet, P. Schjerling, S. Vaulont, J. F. P. Wojtaszewski, and E. A. Richter Role of AMPK{alpha}2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E331 - E339. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fujii, N. Jessen, and L. J. Goodyear AMP-activated protein kinase and the regulation of glucose transport Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E867 - E877. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yu, M. F. Hirshman, N. Fujii, J. M. Pomerleau, L. E. Peter, and L. J. Goodyear Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase {gamma}3-subunit differentially regulates glycogen accumulation Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E557 - E565. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Treebak, S. Glund, A. Deshmukh, D. K. Klein, Y. C. Long, T. E. Jensen, S. B. Jorgensen, B. Viollet, L. Andersson, D. Neumann, et al. AMPK-Mediated AS160 Phosphorylation in Skeletal Muscle Is Dependent on AMPK Catalytic and Regulatory Subunits. Diabetes, July 1, 2006; 55(7): 2051 - 2058. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. B. Dyck and G. D. Lopaschuk AMPK alterations in cardiac physiology and pathology: enemy or ally? J. Physiol., July 1, 2006; 574(1): 95 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Jorgensen, E. A. Richter, and J. F. P. Wojtaszewski Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise J. Physiol., July 1, 2006; 574(1): 17 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gregor, A. Zeold, S. Oehler, K. A. Marobela, P. Fuchs, G. Weigel, D. G. Hardie, and G. Wiche Plectin scaffolds recruit energy-controlling AMP-activated protein kinase (AMPK) in differentiated myofibres J. Cell Sci., May 1, 2006; 119(9): 1864 - 1875. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Davies, D. J. Wells, K. Liu, H. R. Whitrow, T. D. Daniel, R. Grignani, C. A. Lygate, J. E. Schneider, G. Noel, H. Watkins, et al. Characterization of the role of {gamma}2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1942 - H1951. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Hardie and K. Sakamoto AMPK: A Key Sensor of Fuel and Energy Status in Skeletal Muscle Physiology, February 1, 2006; 21(1): 48 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Barnes, Y. C. Long, T. L. Steiler, Y. Leng, D. Galuska, J. F.P. Wojtaszewski, L. Andersson, and J. R. Zierath Changes in Exercise-Induced Gene Expression in 5'-AMP-Activated Protein Kinase {gamma}3-Null and {gamma}3 R225Q Transgenic Mice Diabetes, December 1, 2005; 54(12): 3484 - 3489. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Ryder, Y. C. Long, E. Nilsson, M. Mahlapuu, and J. R. Zierath Effects of calcineurin activation on insulin-, AICAR- and contraction-induced glucose transport in skeletal muscle J. Physiol., September 1, 2005; 567(2): 379 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jessen and L. J. Goodyear Contraction signaling to glucose transport in skeletal muscle J Appl Physiol, July 1, 2005; 99(1): 330 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Wright, P. C. Geiger, J. O. Holloszy, and D.-H. Han Contraction- and hypoxia-stimulated glucose transport is mediated by a Ca2+-dependent mechanism in slow-twitch rat soleus muscle Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1062 - E1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. P Wojtaszewski, J. B Birk, C. Frosig, M. Holten, H. Pilegaard, and F. Dela 5'AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes J. Physiol., April 15, 2005; 564(2): 563 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fraser, P. Mount, R. Hill, V. Levidiotis, F. Katsis, D. Stapleton, B. E. Kemp, and D. A. Power Regulation of the energy sensor AMP-activated protein kinase in the kidney by dietary salt intake and osmolality Am J Physiol Renal Physiol, March 1, 2005; 288(3): F578 - F586. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Barnes, S. Marklund, T. L. Steiler, M. Walter, G. Hjalm,, V. Amarger, M. Mahlapuu, Y. Leng, C. Johansson, D. Galuska, et al. The 5'-AMP-activated Protein Kinase {gamma}3 Isoform Has a Key Role in Carbohydrate and Lipid Metabolism in Glycolytic Skeletal Muscle J. Biol. Chem., September 10, 2004; 279(37): 38441 - 38447. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Iglesias, S. M. Furler, G. J. Cooney, E. W. Kraegen, and J.-M. Ye AMP-Activated Protein Kinase Activation by AICAR Increases Both Muscle Fatty Acid and Glucose Uptake in White Muscle of Insulin-Resistant Rats In Vivo Diabetes, July 1, 2004; 53(7): 1649 - 1654. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |